Work

1,25-Dihydroxyvitamin D3 enhances the susceptibility of breast cancer cells to doxorubicin-induced oxidative damage.

Year: 1999

Type: article

Source: PubMed

Authors: A Ravid, D Rocker, A Machlenkin, C Rotem, A Hochman, G Kessler-Icekson, U A Liberman, R Koren

Institution: Rabin Medical Center

Language: English

Topic: Vitamin D Research Studies

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1580182663

FWCI: 4.476

Cites: 38

Cited by: 160

Related to: 10